PANCREATIN RFF

Medicinal product

(Invented) name

PANCREATIN RFF

Active substance (s)

Kasos milteliai (Proteazė/Lipazė/Amilazė)

Strength

240 mg (400 V/10000 V/7500 V)

Pharmaceutical form

skrandyje neirios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A09AA02, Multienzymes (lipase, protease etc.)

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2024-06-28

Date of renewal

Documents

2207_PANCREATIN RFF 10000 V PZ OTC_2024-06-28.docx

2207_PANCREATIN RFF 10000 V PL_2024-06-28.docx

2207_PANCREATIN RFF 10000 V PZ_RX_2024-06-28.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kasos milteliai (Proteazė/Lipazė/Amilazė)	240 mg (400 V/10000 V/7500 V)

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113971	100087	1100087	lizdinė plokštelė	N10		Nereceptinis	LT/L/24/2207/001	Netiekiama	-	-	No	-	-	Download
113972	100088	1100088	lizdinė plokštelė	N20		Nereceptinis	LT/L/24/2207/002	Netiekiama	-	-	No	-	-
113973	100089	1100089	lizdinė plokštelė	N50		Nereceptinis	LT/L/24/2207/003	Netiekiama	-	-	No	-	-
113974	100090	1100090	lizdinė plokštelė	N60		Receptinis	LT/L/24/2207/004	Tiekiama	2025-08-26	-	No	-	-

Stadijos

Data	Stadija
2024-06-28	Registruotas